Binding Site

Our Products
The Science
Support

Customer Document Portal
Contact

Select a Language

English
Simplified Chinese

English

Freelite®
Subclasses
Optilite®

Monoclonal Gammopathies
The Kidney & Plasma Cell Disorders
Central Nervous System Disorders
Immunodeficiency

Need assistance?
Technical Support
Resources
Scientific Support
Global Patient Groups

Our Products
The Science
Support

Our Story
News and Events
Careers
Privacy policy

Customer Document Portal
Contact

Select a Language

English
Simplified Chinese

English

Home / Support / Resources / Publications / Determining the Clinical Significance of Monoclonal Gammopathy of Undertermined Significance: A SEER - Medicare Population Analysis

Determining the Clinical Significance of Monoclonal Gammopathy of Undertermined Significance: A SEER - Medicare Population Analysis

Author
Ronald S Go et al.

Reference
MKG815

Journal
Clinical Lymphoma, Myeloma & Leukemia, Vol 15 No 3. 177-186

Date
01 January 2015

Order

This paper is available to order

Order Publication

Our Products
The Science
Support

Home
News and Events
Careers
Privacy policy
Terms & conditions
Modern Slavery Statement
Legal

Stay connected

Join us on our social channels

© Copyright 2021 The Binding Site Group Ltd.

Freelite, Hevylite, SPA_PLUS and Optilite are registered trademarks of The Binding Site Group Ltd (Birmingham, UK) in certain countries.